Published in
Public Library of Science, PLoS Neglected Tropical Diseases, 2(10), p. e0004343, 2016
DOI: 10.1371/journal.pntd.0004343
Links
- Public Library of Science
- ORCID
- [doaj.org] | PDF
- [hdl.handle.net] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [diposit.ub.edu] | PDF
Tools
The BENEFIT Trial: Where Do We Go from Here?
Journal article published in 2016 by
Bernard Pecoul,
Carolina Batista,
Eric Stobbaerts,
Isabella Ribeiro,
Rafael Vilasanjuan,
Joaquim Gascon,
Maria Jesus Pinazo 
,
Silvia Moriana,
Silvia Gold,
Ana Pereiro,
Miriam Navarro,
Faustino Torrico,
Maria Elena Bottazzi,
Peter J. Hotez
,
Silvia Moriana,
Silvia Gold,
Ana Pereiro,
Miriam Navarro,
Faustino Torrico,
Maria Elena Bottazzi,
Peter J. Hotez
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
In the next five years, we can now project that 200,000 people living with Chagas disease will die from heart disease and related complications. We urgently need to redouble our efforts to identify and treat young people who are still in the early stages of their illness, but ultimately we need to find better treatments and new cures.